Recently, a few studies have indicated that several ferroptosis-related genes such as TP53, GPX4, SLC7A11, and ACSL4 could regulate drug-induced ferroptosis in CRC; however, the relationship between their expressions with the clinical outcome of patients with CRC remains unknown. This evidence concerns the gene TP53 and colorectal carcinoma.